See All Slides - tctmd.com

Slides

Presentation TCT 2012

Health Care Reform, Payment Reform, and the Implications of Accountable Care Organizations

Presenter: James Palazzo

October 23, 2012

Presentation TCT 2012

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

Presenter: Michael Maeng

October 23, 2012

Presentation TCT 2012

CTSN Trials: Rationale and Status

Presenter: Michael Argenziano

October 23, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Presenter: Jean-Fran?ois Tanguay

October 23, 2012

Presentation TCT 2012

Pro: Ticagrelor!

Presenter: David Kong

October 23, 2012

Presentation TCT 2012

The ART Stent: Design and Early First-in-Man Experiences

Presenter: Jean Fajadet

October 23, 2012

Presentation TCT 2012

SAVR Still the Way for Most!

Presenter: Lars Svensson

October 23, 2012

Presentation TCT 2012

Perspective 2

Presenter: Christopher Nelson

October 23, 2012

Presentation TCT 2012

Drug-Eluting Stent Systems: Design Differences and Comparative Effectiveness and Safety

Presenter: Duane Pinto

October 23, 2012

Advertisement

Slides

Health Care Reform, Payment Reform, and the Implications of Accountable Care Organizations

TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark

CTSN Trials: Rationale and Status

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Pro: Ticagrelor!

The ART Stent: Design and Early First-in-Man Experiences

SAVR Still the Way for Most!

Perspective 2

Drug-Eluting Stent Systems: Design Differences and Comparative Effectiveness and Safety

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content